HIV/HBV coinfection and liver disease

This trial is enrolling now. Depending on eligibility and available places in your area, you may be able to enrol in this trial.

About this trial

This study will investigate the impact hepatitis B has on liverA large organ, located in the upper right abdomen, which assists in digestion by metabolising carbohydrates, fats and proteins, stores vitamins and minerals, produces amino acids, bile and cholesterol, and removes toxins from the blood. disease in people who also have HIV and are currently on HIV treatments. It will also monitor to see if anyone develops any resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. to their HIV treatments because of their hepatitis B.

It involves six-monthly visits and physical examinations to track your health progression over five years

Official title:

Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) co-Infection and Liver Disease

What is this trial studying?

other –

How many participants will this trial enrol?

70 (The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.)

How long is this trial planned to go for?

Participants in this trial will be asked to follow the trial protocol for 5 years.

Links to further information:

• http://clinicaltrials.gov/ct2/show/NCT00637429?term=HIV+HBV&cntry1=PA%3AAU&rank=2

Related trials:

• (http://napwa.org.au/node/)
• (http://napwa.org.au/node/)

Who can enrol in this trial?

You may be eligible to participate in this trial if you meet the following criteria:

• At least 18 years old
• Currently taking HIV treatments
• HIV-positive
• Positive test for active hepatitis B virus (HBV) infection
• Have active hepatitis B or C

This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.

If you are interested in enrolling in this trial

Before making the decision to participate in any clinical trial, NAPWA recommends that you discuss the potential benefits and risks of participation with your treating doctor. Your doctor can also provide advice about your eligibility to participate in the trial.

While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.

Before making the decision to participate in any clinical research, visit the NAPWA website for background information on participating in clinical research.

Contact NAPWA if you have any questions or comments about this trial.